Rep. Jonathan Jackson, the Illinois Democrat who inherited his father Jesse's political machine and his father's flair for the floor speech, has been quiet in the Google News cycle this week. But on Bluesky, his name is circulating for a June 29 floor statement honoring a constituent and for amplifying the story of Venezuelans missing after a hotel collapse following their deportation. Good constituent work. Standard congressional visibility. Meanwhile, the financial disclosures sitting on file at the House clerk's office tell a different and more specific story: five trades in 90 days, including a Visa sale worth between $50,000 and $100,000, executed by a member who sits on the House Committee on Agriculture and the House Committee on Foreign Affairs. The committee assignments are relevant here. The Visa sale has a flag attached to it. Read on.
The Social Moment
Jackson's Bluesky presence this week runs to exactly three posts in circulation. One captures his June 29 floor tribute to the late Khadijah Farmer. Another places him in a list of members on a committee roster. The third quotes him calling attention to Venezuelans reported missing after a hotel collapse in the aftermath of their U.S. Deportation.
None of that's the story. The story is what he filed with the House clerk in April.
Five Trades, 90 Days
Jackson's full disclosure record at Blind Trust shows five trades between April 15 and April 24, 2026. Here's the tape:
- April 15: Sale of Tenet Healthcare (THC), $1,000–$15,000.
- April 20: Sale of Tenet Healthcare (THC), $15,000–$50,000.
- April 20: Purchase of Procter & Gamble (PG), $15,000–$50,000.
- April 24: Sale of O'Reilly Automotive (ORLY), $1,000–$15,000.
- April 24: Sale of Visa (V), $50,000–$100,000.
He sold Tenet Healthcare twice in five days, then rotated out of Visa in the biggest single disclosed transaction of the window. The Procter & Gamble buy sits in the middle like a palate cleanser.
Tenet Healthcare is a hospital chain. Jackson sits on Agriculture and Foreign Affairs. Neither committee governs hospital companies. The Tenet sales are just trades. The Visa sale is something else.
The Visa Sale and the Committee Overlap
Visa is a payments company. Payments infrastructure, consumer financial products, card-network regulation: that's Financial Services territory. Jackson's disclosed committee overlap record flags the April 24 Visa sale explicitly under Financial Services jurisdiction.
The sale cleared between $50,000 and $100,000. The 30-day alpha on that trade was negative 0.3 percent versus the S&P 500. Not a profitable exit. The timing is the thing, not the return.
Members are required to disclose. They are not required to divest, recuse, abstain, blush, or look up from their phones. That's the rule. Yes, really.
Jackson also sold Linde (LIN) in May 2025, $50,000 to $100,000, flagged under a chemicals-sector committee overlap. That one produced negative 5.5 percent 30-day alpha. Two of his two flagged committee-overlap trades both went the wrong direction after he sold. Small sample. Public record.
The Full Scorecard
Blind Trust has scored 97 of Jackson's disclosed trades against the S&P 500. The record: 48 positive, 49 negative, mean 30-day alpha of essentially zero. That's a coin flip with extra paperwork. It's the full sample. Not a highlight reel.
The best trade in the scored set was a September 2025 purchase of Robinhood Markets (HOOD) for $1,000 to $15,000, which put up 43.2 percent 30-day alpha. No committee overlap. He also bought GE Vernova (GEV) in January 2026 for $15,000 to $50,000 and cleared 21.1 percent in 30 days. No overlap there either. Meta Platforms (META) in April 2025, $1,000 to $15,000: 17.0 percent alpha.
The worst trades are equally honest. He sold Robinhood in January 2026 for $1,000 to $15,000 and the stock proceeded to gain 29.5 percent against the market in the next 30 days. That's negative 29.5 percent alpha on a sale. He also sold Doximity (DOCS) in November 2025 for $15,000 to $50,000 and gave up 23.2 percent in alpha. Palantir Technologies (PLTR), sold in January 2026 for $15,000 to $50,000: negative 21.7 percent alpha.
No committee overlaps on any of those. No pattern beyond the ordinary randomness of a member with a brokerage account and a busy floor schedule.
The Robinhood sequence is worth a beat. Jackson bought HOOD in September 2025 and cleared 43.2 percent in 30 days. He then sold HOOD in January 2026 and gave up 29.5 percent in alpha because the stock kept climbing without him. One ticker, two trades, roughly opposite outcomes. The market didn't care about his committee assignments either time.
The Votes in Context
Jackson voted on eight bills in the recent window. The most financially relevant is the Financial Exploitation Prevention Act of 2025, which passed June 25 with his Yea vote. The bill targets elder financial exploitation in securities markets. Jackson's committee assignments are Agriculture and Foreign Affairs, not Financial Services. That's a floor vote, not a committee action. He has no special oversight claim there.
He was not voting on June 29 when the TRIA Program Reauthorization Act passed. TRIA covers terrorism-risk insurance, which sits squarely in Financial Services jurisdiction. Not voting, for whatever reason, on a financial-sector bill on the same day his name was circulating on social media for a floor tribute. The vote and the tribute are unrelated. The disclosure record doesn't require them to be related. They're just both on the same date.
The bills he voted Nay on include the Veterans 2nd Amendment Protection Act and the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act, both May 21. Both passed without him. Neither has anything to do with his disclosed trades or committee remit.
The Broader Picture on Jackson's Portfolio
The April cluster is active by Jackson's disclosed standards. Two Tenet Healthcare sales in five days suggests a position wind-down. The O'Reilly Automotive sale is small, $1,000 to $15,000. The Procter & Gamble buy lands in the $15,000 to $50,000 range and is the only purchase in the 90-day window.
Procter & Gamble is a consumer staples company. Jackson's Agriculture Committee has jurisdiction over food and nutrition programs. The Nutrition and Foreign Agriculture subcommittee is one of his assignments. Consumer staples and agricultural supply chains are not the same thing, but they share a Venn diagram in ways that financial-sector holdings don't. The buy occurred. It doesn't carry the same explicit overlap flag as the Visa sale. The Visa flag is documented. The Procter & Gamble purchase is just a purchase in a sector adjacent to his committee work, by the most generous reading.
His 97-trade scored sample at basically zero mean alpha suggests a portfolio that tracks the market without consistently beating it. That's unremarkable in isolation. What's not unremarkable is a $50,000-to-$100,000 sale in a sector covered by a committee he sits adjacent to, logged in the public record and available to anyone who looks.
The System, as Designed
The STOCK Act requires disclosure within 45 days. It does not require members to explain their trades, recuse themselves from related votes, or acknowledge the overlap. The system produces a public record. It does not produce accountability on its own. Someone has to read the filings.
Jackson's office has not commented, because no one has asked. His filings are current. He is compliant. The question of whether compliant is sufficient is one Congress has declined to answer for itself since 2012, when the STOCK Act passed with great fanfare and was quietly amended the following year to reduce its disclosure requirements for staffers.
Jackson sits on Agriculture and Foreign Affairs. He is selling Visa. He is buying Procter & Gamble. He is giving floor speeches about constituents and deported Venezuelans. All of this is on the record. The receipts are public. Make of them what you make of them.